4//SEC Filing
CADENCE PHARMACEUTICALS INC 4
Accession 0000904454-14-000327
CIK 0001333248operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 7:02 PM ET
Size
5.2 KB
Accession
0000904454-14-000327
Insider Transaction Report
Form 4
DP VI Associates, L.P.
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-03-19$14.00/sh−78,369$1,097,166→ 0 total
Footnotes (1)
- [F1]In connection with the acquisition of the Issuer by Mallinckrodt plc ("Parent") on March 19, 2014, and pursuant to the terms of the Agreement and Plan of Merger by and among the Issuer, Parent and Madison Merger Sub, Inc. ("Merger Sub") dated February 10, 2014, Merger Sub acquired all of the issued and outstanding shares of Common Stock (the "Shares") for a purchase price of $14.00 per Share.
Documents
Issuer
CADENCE PHARMACEUTICALS INC
CIK 0001333248
Entity typeoperating
Related Parties
1- filerCIK 0001333248
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 7:02 PM ET
- Size
- 5.2 KB